Penserra Capital Management LLC Voyager Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.47 - $5.55 $2,148 - $4,828	-870 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.63 - $4.12 $26 - $41	10 Added 1.16%	870 $2,000
Q2 2021 Aug 12, 2021	BUY	$3.94 - $5.44 $39 - $54	10 Added 1.18%	860 $3,000
Q1 2021 May 13, 2021	SELL	$4.61 - $9.04 $46 - $90	-10 Reduced 1.16%	850 $4,000
Q4 2020 Feb 12, 2021	BUY	$7.15 - $12.28 $3,861 - $6,631	540 Added 168.75%	860 $6,000
Q3 2020 Nov 13, 2020	BUY	$10.01 - $13.75 $3,203 - $4,400	320 New	320 $3,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.